
-Obtained Approvals of CTAs in Multiple Countries for CTX001 in β-thalassemia and SCD--Initiation of ...

Dublin, Feb. 27, 2018 (GLOBE NEWSWIRE) -- The "Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, ...
Click to continue to site. Closing